Bailly, B <br/><br/>
Targeting human respiratory syncytial virus transcription anti-termination factor M2-1 to inhibit in vivo viral replication.  [electronic resource] 

 -  Scientific reports  05 2016 
 - 25806 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2045-2322 
<br/><br/><label>Standard No.: </label>10.1038/srep25806  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkaloids--pharmacology<br/>Animals<br/>Cell Line<br/>DNA-Directed RNA Polymerases--metabolism<br/>Disease Models, Animal<br/>Drug Resistance, Viral--drug effects<br/>Female<br/>Gene Expression Regulation, Viral--drug effects<br/>Humans<br/>Mice, Inbred BALB C<br/>Models, Molecular<br/>Respiratory Syncytial Virus Infections--drug therapy<br/>Respiratory Syncytial Virus, Human--drug effects<br/>Smoothened Receptor--metabolism<br/>Transcription, Genetic--drug effects<br/>Veratrum--chemistry<br/>Veratrum Alkaloids--chemistry<br/>Viral Proteins--metabolism<br/>Virus Replication--drug effects